Monitoring glucose to detect early pancreatic islet graft loss
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study uses a continuous glucose monitor (CGM) to watch for early signs that a transplanted pancreatic islet graft may be losing function. The goal is to catch problems sooner and help keep the transplant working well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have insulin-dependent diabetes (such as type 1, or related to chronic pancreatitis, MODY, or cystic fibrosis).
- You have completed a full cycle of pancreatic islet transplant, either alone, after a kidney transplant, or at the same time as a kidney transplant.
- If you received fewer than 10,000 IEQ/kg of islet cells, you must have become insulin-independent after transplant.
- You agree to have your medical data used for this research.
- You must be willing to wear a continuous glucose monitor (CGM) device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new continuous glucose monitor (a small sensor that checks blood sugar levels) to see how well and safely it works in people with type 1 diabetes. You'll wear the sensor for 15 days and attend three clinic visits to check its accuracy against blood samples.
This study tests a small sensor called a continuous glucose monitor (CGM) that tracks your blood sugar after kidney transplant. It helps doctors see how your body handles sugar during recovery.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
This study checks how well transplanted islet cells are working over time and monitors long-term safety. If you previously received an islet transplant and are still using medicine to prevent rejection, you may be followed again.
This study checks whether using a continuous glucose monitor (a sensor that tracks sugar throughout the day) is helpful and practical for people with a recent kidney transplant and type 2 diabetes on insulin. You may need to wear the sensor continuously and still do finger-stick glucose checks for safety.
This study compares two ways of tracking blood sugar in people with type 2 diabetes who use insulin. It aims to see if one method helps manage glucose better, which could improve daily control and long-term health.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.